Viewing Study NCT06045195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2026-01-29 @ 8:06 AM
Study NCT ID: NCT06045195
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-06
First Post: 2023-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma
Sponsor: University of Cologne
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PD-1 inhibitor View
None advanced stage View
None first line treatment View